Donate

CAR T-cell in Lymphoma – Sydney Dinner

Join us for dinner and learn about the latest in CAR T-cell treatment for Lymphoma.

Guest Speaker Bio

Ty Simpson NP candidate

Ty is a Nurse Practitioner Candidate specialising in CAR-T therapy at the Alfred Hospital in Melbourne. He oversees the coordination of care for patients receiving both standard-of-care and investigational CAR-T treatments, managing a diverse caseload that includes malignant haematology, oncology, and autoimmune conditions. As co-chair of the Australasian CAR-T Nurses Group, Ty collaborates with colleagues across the region to establish best practice guidelines for CAR-T nursing. Ty was recently recognised for his significant contribution to patient management and the nursing profession, and was awarded 2025 Australian Nurse of the Year.   

Dr Catelyn Cashion 

Dr Catelyn Cashion is a dual trained haematologist with an interest in lymphoma and cellular therapies. She is currently the bone marrow transplant and cellular therapies fellow at Westmead Hospital. 

Agenda

ARRIVAL 6:30pm Welcome address by Nicole Weekes Lymphoma Care Nurse

Presentation 1

 

6:50-7pm

Gilead representative to share CAR-T updates

Presentation 2

7-7:45pm

Ty Simpson – Nurse Practioner:

Nursing the CAR-T patient, what you need to know from beginning to transition back to the patient’s home centre.

Presentation 3

8-8:45pm

Dr Catelyn Cashion – CAR T-cell Fellow:

How CART cell therapy works, latest updates and recommendations.

Meeting close

9pm

  

Strictly limited seating - RSVP 18th August
Strictly limited seating - RSVP 18th August
Details
Date: Tuesday 26th of August 2025
Time: 6:30pm AEST - 9:00pm AEST
Location: Novotel Darling Harbour – Hunter Room
100 Murray Street, Sydney NSW 2000
Register to attend
Download Flyer

Support and information

Patient Online Forum

Find Out More

Order Our Resources

Find Out More

Fundraise for us

Get started

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.